Paper46777
Morphological basis for the cytolytic effect of vinblastine and vincristine on cultured human leukemic lymphoblasts.
Krishan A and 1 other. Cancer Res, 1975. Cited by 57 papers, by iCite.
Cite this record
ConductScience Library. Morphological basis for the cytolytic effect of vinblastine and vincristine on cultured human leukemic lymphoblasts. Papers, record 46777. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/46777
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Morphological basis for the cytolytic effect of vinblastine and vincristine on cultured human leukemic lymphoblasts.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukemia, Lymphoid | Major topic |
| Lymphocytes | Major topic |
| Vinblastine | Major topic |
| Vincristine | Major topic |
| Bleomycin | |
| Cell Line | |
| Doxorubicin | |
| Humans |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27620987 | Microtubule destabilising agents: far more than just antimitotic anticancer drugs. | Br J Clin Pharmacol | 2017 | https://conductscience.org/library/papers/27620987 | PubMed |
| 8104946 | Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine. | J Cancer Res Clin Oncol | 1993 | https://conductscience.org/library/papers/8104946 | PubMed |
| 6713514 | In vivo shedding of apical plasma membrane in the thyroid follicle cells of the mouse. | Cell Tissue Res | 1984 | https://conductscience.org/library/papers/6713514 | PubMed |
| 6189661 | Clinical pharmacokinetics of commonly used anticancer drugs. | Clin Pharmacokinet | 1983 | https://conductscience.org/library/papers/6189661 | PubMed |
| 4066762 | Cell surface tubulin in leukemic cells: molecular structure, surface binding, turnover, cell cycle expression, and origin. | J Cell Biol | 1985 | https://conductscience.org/library/papers/4066762 | PubMed |
| 993346 | The effects of colcemid on hematopoiesis in the mouse. | J Clin Invest | 1976 | https://conductscience.org/library/papers/993346 | PubMed |
| 889685 | Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation. | Br J Cancer | 1977 | https://conductscience.org/library/papers/889685 | PubMed |
| 588443 | Electron microscopy on the effect of vinblastine on the telencephalic wall of the rat fetus. | Br J Exp Pathol | 1977 | https://conductscience.org/library/papers/588443 | PubMed |
| 324507 | Ultrastructure of cell surface abnormalities in neoplastic histiocytes. | Br J Cancer | 1977 | https://conductscience.org/library/papers/324507 | PubMed |
| 268292 | Ropalocytosis in acute leukemia. | Experientia | 1977 | https://conductscience.org/library/papers/268292 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/46777
GET https://conductscience.org/api/papers/v1/46777/authors